Cardiff Oncology Reports Q3 2026 Results, $30.4 Million Nine-Month Net Loss

Cardiff Oncology reported a net loss of $8.9 million for the third quarter of 2026 and $30.4 million for the first nine months of the year. The company ended September with $33.8 million in cash, cash equivalents and short-term investments, which it expects to fund operations through the third quar…